BO

Black Opal Ventures

North America, New York, United States, New York

Description

Black Opal is a venture capital investment firm.

Investor Profile

Black Opal Ventures has made 7 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (57%)
  • Series A (29%)
  • Seed (14%)

Country Focus

  • United States (71%)
  • United Kingdom (29%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Life Science
  • B2b
  • Natural Language Processing
  • Saas
  • Virtual Assistant
  • Machine Learning
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Black Opal Ventures frequently co-invest with?

Co-Investments: 1
ACME Capital
North America, Florida, United States, Boca Raton
Co-Investments: 1
Macquarie Capital
Oceania, New South Wales, Australia, Sydney
Co-Investments: 2
CH
North America, California, United States, Ross
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 2
Future Positive Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Atlantic Health System
North America, New Jersey, United States, Newton
Co-Investments: 1
Stride.VC
Europe, England, United Kingdom, London
Co-Investments: 1
Muse Capital
North America, California, United States, Sherman Oaks
Co-Investments: 1

What are some of recent deals done by Black Opal Ventures?

Conceivable Life Sciences

New York, New York, United States

Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.

BiotechnologyLife ScienceMedical
Series AJan 14, 2025
Amount Raised: $18,000,000
Hyro

New York, New York, United States

Hyro is a plug-and-play conversational AI platform that enables enterprises to add voice and text capabilities to their digital channels.

Artificial Intelligence (AI)B2BNatural Language ProcessingSaaSVirtual Assistant
Series BDec 10, 2024
Amount Raised: $15,000,000
Outpace Bio

Seattle, Washington, United States

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

BiotechnologyHealth CareLife SciencePharmaceutical
Series BAug 1, 2024
Amount Raised: $144,000,000
Hyro

New York, New York, United States

Hyro is a plug-and-play conversational AI platform that enables enterprises to add voice and text capabilities to their digital channels.

Artificial Intelligence (AI)B2BNatural Language ProcessingSaaSVirtual Assistant
Series BMay 31, 2023
Amount Raised: $20,000,000
Optellum

Oxford, Oxfordshire, United Kingdom

Optellum develops an imaging biomarker for smart lung cancer detection.

Health CareMachine LearningMedical DeviceSoftware
Series ASep 27, 2022
Amount Raised: $14,000,000
Empatica

Cambridge, Massachusetts, United States

Empatica is an affective computing company focused on human data analytics.

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningWearables
Series BAug 2, 2022
Amount Raised: $25,949,980
Synteny.Ai

London, England, United Kingdom

Synteny.Ai Syntney decodes the signals of immune repertoires to help biotech research and pharma companies with disease discoveries.

BiopharmaBiotechnology
SeedJan 1, 2022